Turnstone Biologic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) and Turnstone Biologics (NASDAQ:TSBX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends. Earnings and Valuation This table compares Poseida […]

Venrock took a large position in biotech Apogee Therapeutics. Versant disclosed a big stake in pharmaceutical firm Turnstone Biologics.

One of Ottawa’s most highly-touted biotech startups has secured the city’s largest venture capital deal in nearly three years. Turnstone Biologics was cofounded by three Ontario physicians including Dr. John Bell of the Ottawa Hospital and is developing cancer-fighting viruses. On Wednesday, the firm said it had completed a US$80-million series-D funding round led by PFM Health Sciences and Point72. “This oversubscribed financing will allow us to advance our vision to benefit millions of cancer patients underserved by current treatment options,” said Turnstone president and CEO Sammy ...

One of Ottawa’s most highly-touted biotech startups has secured the city’s largest venture capital deal in nearly three years. Turnstone Biologics was cofounded by three Ontario physicians including Dr. John Bell of the Ottawa Hospital and is developing cancer-fighting viruses. On Wednesday, the firm said it had completed a US$80-million series-D funding round led by PFM Health Sciences and Point72. “This oversubscribed financing will allow us to advance our vision to benefit millions of cancer patients underserved by current treatment options,” said Turnstone president and CEO Sammy ...